Table 4.
MicroRNA | Intercalent Agent | Platform | Amplification of Signal Elements | Tech | Linear Range | LOD | Real-Samples Application | Ref |
---|---|---|---|---|---|---|---|---|
miRNA-155 | OB | GCE/GO/GNR | - | DPV | 2.0 fM–8.0 pM | 0.6 fM | Spiked human plasma | [157] |
miRNA-21 | TB | GCE/AuNPs-Ppy | - | DPV | 100 aM–1 nM | 78 aM | Spiked human serum. | [138] |
miRNA-196a | MB | AuE | DNA extension reaction | DPV | 0.05 fM–50 pM | 15 aM | Spiked plasma | [148] |
miRNA-486-5p | Thinonine | GCE/FeCN/AuNPs | FeCN | DPV | 1 fM–1000 pM | 8.53 fM | Human lung A549 cells | [158] |
miRNA-141 | RuHex | AuE | HP-AuNPs | DPV | 0–10 nM | 25.1 aM | Human breast cancer cells MDA-MB-231 | [150] |
miRNA-21 | RuHex | AuE | AuNPs enrichment by bridge DNA, | Chronocoulometry | 0.1fM–0.1nM | 68 aM | Serum samples from lung cancer patients | [159] |
miRNA-21 | RuHex | GCE/AuNPs@MoS2 | AuNPs@MoS2 | DPV | 10 fM–1 nM | 0.78 fM | Spiked human serum | [160] |
miRNA-21 | Molybdophosphate | AuE | HCR | SWV | 1 fM–1 nM | 0.78 fM | Spiked human serum | [161] |
miRNA-21 | CuNCs | AuE | HCR | DPSV | 10 pM–0.1 fM | 10 aM | Spiked blood sample | [162] |
miRNA-21 | Hemin | AuE | HCR | DPV | 15 fM–250 pM | 13.5 fM | Spiked human serum | [152] |
miRNA-199 a | AgNPs | AuE | C-rich loop DNA templates | DPV | 1.0 fM–0.1 nM | 0.64 fM | Spiked human serum | [142] |
Abbreviations: GCE, glassy carbon electrode; MB, methylene blue; DPV, differential pulse voltammetry; AuE, gold electrode; FeCN, iron-embedded nitrogen-rich carbon nanotubes; AuNPs, gold nanoparticles; A549 cells, adenocarcinoma cells; GO, graphene oxide; GNR, gold nanorods; Ppy, polypyrrole; RuHex, hexaammineruthenium III chloride; HP-AuNPs, hairpin-modified gold nanoparticles; MDA-MB-231: human breast cancer cells; HCR, hybridization chain reaction; SWV, square wave voltammetry; CuNCs, copper nanoclosters; DPSV, differential pulse stripping voltammetry; AgNPs, silver nanoparticles; C-rich loop DNA templates, cytosine-rich loop DNA templates; TB, toluidine blue; OB, oracet blue.